TipRanks
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market
AJANTPHARM
Ajanta Pharma Limited
RESEARCH TOOLSreports
Want to see IN:AJANTPHARM full AI Analyst Report?

Ajanta Pharma Limited (AJANTPHARM) Ratios

6 Followers

Ajanta Pharma Limited Ratios

IN:AJANTPHARM's free cash flow for Q1 2027 was ₹0.54. For the 2027 fiscal year, IN:AJANTPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.25. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.00 2.64 2.85 3.05 2.49
Quick Ratio
 0.00 1.98 1.95 2.12 1.77
Cash Ratio
 0.00 0.07 0.18 0.14 0.29
Solvency Ratio
 -0.29 0.76 0.87 0.89 0.56
Operating Cash Flow Ratio
 0.00 0.36 1.16 0.88 0.69
Short-Term Operating Cash Flow Coverage
 0.00 2.44 446.81 526.89 4.40K
Net Current Asset Value
₹ 45.27B₹ 21.08B₹ 16.18B₹ 16.60B₹ 15.43B
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.04 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.00 0.06 0.01 <0.01 0.01
Debt-to-Capital Ratio
 0.00 0.05 0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
 0.00 1.36 1.32 1.30 1.38
Debt Service Coverage Ratio
 91.59 5.46 46.54 110.20 120.29
Interest Coverage Ratio
 155.44 82.23 54.44 272.92 121.76
Debt to Market Cap
 0.00 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 1.12 22.12 5.44 3.37 3.24
Net Debt to EBITDA
 0.00 0.10 -0.10 -0.07 -0.33
Profitability Margins
Gross Profit Margin
65.01%51.44%75.43%73.50%70.34%
EBIT Margin
25.40%25.56%26.37%26.64%20.07%
EBITDA Margin
28.45%28.74%29.51%29.86%23.55%
Operating Profit Margin
37.75%24.29%24.60%46.75%19.00%
Pretax Profit Margin
25.85%25.26%25.92%26.47%19.91%
Net Profit Margin
19.65%19.37%20.06%19.39%15.71%
Continuous Operations Profit Margin
19.65%19.37%20.06%19.39%15.71%
Net Income Per EBT
76.00%76.65%77.40%73.27%78.90%
EBT Per EBIT
68.48%103.99%105.38%56.61%104.81%
Return on Assets (ROA)
0.00%17.16%18.35%17.60%12.57%
Return on Equity (ROE)
25.67%23.33%24.28%22.88%17.35%
Return on Capital Employed (ROCE)
0.00%27.95%28.08%52.58%20.09%
Return on Invested Capital (ROIC)
0.00%20.47%21.66%38.40%15.81%
Return on Tangible Assets
0.00%17.27%18.52%17.65%12.59%
Earnings Yield
2.66%3.01%2.81%2.90%3.80%
Efficiency Ratios
Receivables Turnover
 0.00 2.94 3.88 3.38 3.54
Payables Turnover
 0.00 4.87 2.48 2.41 2.63
Inventory Turnover
 0.00 2.82 1.25 1.35 1.36
Fixed Asset Turnover
 0.00 2.62 2.42 2.45 2.20
Asset Turnover
 0.00 0.89 0.91 0.91 0.80
Working Capital Turnover Ratio
 4.98 2.62 2.49 2.38 2.26
Cash Conversion Cycle
 0.00 178.55 239.71 227.63 232.23
Days of Sales Outstanding
 0.00 124.21 94.10 108.13 103.07
Days of Inventory Outstanding
 0.00 129.37 292.69 271.09 268.15
Days of Payables Outstanding
 0.00 75.02 147.08 151.59 138.99
Operating Cycle
 0.00 253.57 386.79 379.22 371.23
Cash Flow Ratios
Operating Cash Flow Per Share
 22.73 41.34 92.45 62.35 61.80
Free Cash Flow Per Share
 8.84 12.11 67.05 50.24 48.18
CapEx Per Share
 13.88 29.23 25.40 12.10 13.62
Free Cash Flow to Operating Cash Flow
 0.39 0.29 0.73 0.81 0.78
Dividend Paid and CapEx Coverage Ratio
 1.64 0.72 1.73 0.99 3.00
Capital Expenditure Coverage Ratio
 1.64 1.41 3.64 5.15 4.54
Operating Cash Flow Coverage Ratio
 0.00 1.98 24.40 22.25 22.22
Operating Cash Flow to Sales Ratio
 0.05 0.09 0.25 0.19 0.21
Free Cash Flow Yield
0.26%0.43%2.56%2.24%3.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 37.54 33.18 35.58 34.54 26.34
Price-to-Sales (P/S) Ratio
 7.38 6.43 7.14 6.70 4.14
Price-to-Book (P/B) Ratio
 9.41 7.74 8.64 7.90 4.57
Price-to-Free Cash Flow (P/FCF) Ratio
 385.66 231.72 39.04 44.55 25.09
Price-to-Operating Cash Flow Ratio
 150.05 67.86 28.31 35.90 19.56
Price-to-Earnings Growth (PEG) Ratio
 1.69 2.23 2.64 0.84 -1.59
Enterprise Value Multiple
 25.92 22.46 24.10 22.36 17.24
Enterprise Value
 426.04B 351.98B 326.34B 280.93B 151.93B
EV to EBITDA
 25.92 22.46 24.10 22.36 17.24
EV to Sales
 7.38 6.46 7.11 6.68 4.06
EV to Free Cash Flow
 385.66 232.75 38.88 44.41 24.61
EV to Operating Cash Flow
 150.05 68.16 28.20 35.78 19.19
Tangible Book Value Per Share
 362.35 359.05 299.09 282.15 263.84
Shareholders’ Equity Per Share
 362.35 362.38 302.81 283.31 264.44
Tax and Other Ratios
Effective Tax Rate
 0.24 0.23 0.23 0.27 0.21
Revenue Per Share
 462.33 436.49 366.50 334.25 292.12
Net Income Per Share
 90.84 84.53 73.53 64.82 45.89
Tax Burden
 0.76 0.77 0.77 0.73 0.79
Interest Burden
 1.02 0.99 0.98 0.99 0.99
Research & Development to Revenue
 0.02 0.00 0.00 0.05 0.06
SG&A to Revenue
 0.17 0.23 0.24 0.03 0.21
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 <0.01
Income Quality
 0.20 0.49 1.26 0.96 1.06
Currency in INR